The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Suspension Budesonide Market Research Report 2025
Synopsis
Budesonide Inhalation Suspension should be administered via jet nebulizer connected to an air compressor with an adequate air flow, equipped with a mouthpiece or suitable face mask. Ultrasonic nebulizers are not suitable for the adequate administration of Budesonide Inhalation Suspension and, therefore, are not recommended.
The global Injectable Suspension Budesonide market was valued at US$ 4675.7 million in 2023 and is anticipated to reach US$ 5928.7 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
North American market for Injectable Suspension Budesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Injectable Suspension Budesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Injectable Suspension Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Injectable Suspension Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Suspension Budesonide.
Report Scope
The Injectable Suspension Budesonide market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Suspension Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Suspension Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Segment by Type
0.5mg
1mg
Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Suspension Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Suspension Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Budesonide Inhalation Suspension should be administered via jet nebulizer connected to an air compressor with an adequate air flow, equipped with a mouthpiece or suitable face mask. Ultrasonic nebulizers are not suitable for the adequate administration of Budesonide Inhalation Suspension and, therefore, are not recommended.
The global Injectable Suspension Budesonide market was valued at US$ 4675.7 million in 2023 and is anticipated to reach US$ 5928.7 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
North American market for Injectable Suspension Budesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Injectable Suspension Budesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Injectable Suspension Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Injectable Suspension Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Suspension Budesonide.
Report Scope
The Injectable Suspension Budesonide market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Suspension Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Suspension Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Segment by Type
0.5mg
1mg
Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Suspension Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Suspension Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Injectable Suspension Budesonide Market Overview
1.1 Product Overview and Scope of Injectable Suspension Budesonide
1.2 Injectable Suspension Budesonide Segment by Type
1.2.1 Global Injectable Suspension Budesonide Market Value Comparison by Type (2024-2030)
1.2.2 0.5mg
1.2.3 1mg
1.3 Injectable Suspension Budesonide Segment by Application
1.3.1 Global Injectable Suspension Budesonide Market Value by Application: (2024-2030)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Other
1.4 Global Injectable Suspension Budesonide Market Size Estimates and Forecasts
1.4.1 Global Injectable Suspension Budesonide Revenue 2019-2030
1.4.2 Global Injectable Suspension Budesonide Sales 2019-2030
1.4.3 Global Injectable Suspension Budesonide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Suspension Budesonide Market Competition by Manufacturers
2.1 Global Injectable Suspension Budesonide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable Suspension Budesonide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable Suspension Budesonide Average Price by Manufacturers (2019-2024)
2.4 Global Injectable Suspension Budesonide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Suspension Budesonide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Suspension Budesonide, Product Type & Application
2.7 Injectable Suspension Budesonide Market Competitive Situation and Trends
2.7.1 Injectable Suspension Budesonide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Suspension Budesonide Players Market Share by Revenue
2.7.3 Global Injectable Suspension Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Suspension Budesonide Retrospective Market Scenario by Region
3.1 Global Injectable Suspension Budesonide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Suspension Budesonide Global Injectable Suspension Budesonide Sales by Region: 2019-2030
3.2.1 Global Injectable Suspension Budesonide Sales by Region: 2019-2024
3.2.2 Global Injectable Suspension Budesonide Sales by Region: 2025-2030
3.3 Global Injectable Suspension Budesonide Global Injectable Suspension Budesonide Revenue by Region: 2019-2030
3.3.1 Global Injectable Suspension Budesonide Revenue by Region: 2019-2024
3.3.2 Global Injectable Suspension Budesonide Revenue by Region: 2025-2030
3.4 North America Injectable Suspension Budesonide Market Facts & Figures by Country
3.4.1 North America Injectable Suspension Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Suspension Budesonide Sales by Country (2019-2030)
3.4.3 North America Injectable Suspension Budesonide Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Suspension Budesonide Market Facts & Figures by Country
3.5.1 Europe Injectable Suspension Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Suspension Budesonide Sales by Country (2019-2030)
3.5.3 Europe Injectable Suspension Budesonide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Suspension Budesonide Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Suspension Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Suspension Budesonide Sales by Country (2019-2030)
3.6.3 Asia Pacific Injectable Suspension Budesonide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Injectable Suspension Budesonide Market Facts & Figures by Country
3.7.1 Latin America Injectable Suspension Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Suspension Budesonide Sales by Country (2019-2030)
3.7.3 Latin America Injectable Suspension Budesonide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Suspension Budesonide Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Suspension Budesonide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Suspension Budesonide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Suspension Budesonide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Suspension Budesonide Sales by Type (2019-2030)
4.1.1 Global Injectable Suspension Budesonide Sales by Type (2019-2024)
4.1.2 Global Injectable Suspension Budesonide Sales by Type (2025-2030)
4.1.3 Global Injectable Suspension Budesonide Sales Market Share by Type (2019-2030)
4.2 Global Injectable Suspension Budesonide Revenue by Type (2019-2030)
4.2.1 Global Injectable Suspension Budesonide Revenue by Type (2019-2024)
4.2.2 Global Injectable Suspension Budesonide Revenue by Type (2025-2030)
4.2.3 Global Injectable Suspension Budesonide Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Suspension Budesonide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Suspension Budesonide Sales by Application (2019-2030)
5.1.1 Global Injectable Suspension Budesonide Sales by Application (2019-2024)
5.1.2 Global Injectable Suspension Budesonide Sales by Application (2025-2030)
5.1.3 Global Injectable Suspension Budesonide Sales Market Share by Application (2019-2030)
5.2 Global Injectable Suspension Budesonide Revenue by Application (2019-2030)
5.2.1 Global Injectable Suspension Budesonide Revenue by Application (2019-2024)
5.2.2 Global Injectable Suspension Budesonide Revenue by Application (2025-2030)
5.2.3 Global Injectable Suspension Budesonide Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Suspension Budesonide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Injectable Suspension Budesonide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Injectable Suspension Budesonide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Injectable Suspension Budesonide Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Injectable Suspension Budesonide Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cosmo Pharmaceuticals
6.5.1 Cosmo Pharmaceuticals Corporation Information
6.5.2 Cosmo Pharmaceuticals Description and Business Overview
6.5.3 Cosmo Pharmaceuticals Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cosmo Pharmaceuticals Injectable Suspension Budesonide Product Portfolio
6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.6 Salix
6.6.1 Salix Corporation Information
6.6.2 Salix Description and Business Overview
6.6.3 Salix Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Salix Injectable Suspension Budesonide Product Portfolio
6.6.5 Salix Recent Developments/Updates
6.7 Chiesi Farmaceutici
6.6.1 Chiesi Farmaceutici Corporation Information
6.6.2 Chiesi Farmaceutici Description and Business Overview
6.6.3 Chiesi Farmaceutici Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chiesi Farmaceutici Injectable Suspension Budesonide Product Portfolio
6.7.5 Chiesi Farmaceutici Recent Developments/Updates
6.8 Orion Corporation
6.8.1 Orion Corporation Corporation Information
6.8.2 Orion Corporation Description and Business Overview
6.8.3 Orion Corporation Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Orion Corporation Injectable Suspension Budesonide Product Portfolio
6.8.5 Orion Corporation Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cipla Injectable Suspension Budesonide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Synmosa Biopharma
6.10.1 Synmosa Biopharma Corporation Information
6.10.2 Synmosa Biopharma Description and Business Overview
6.10.3 Synmosa Biopharma Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Synmosa Biopharma Injectable Suspension Budesonide Product Portfolio
6.10.5 Synmosa Biopharma Recent Developments/Updates
6.11 Lunan Better Pharma
6.11.1 Lunan Better Pharma Corporation Information
6.11.2 Lunan Better Pharma Injectable Suspension Budesonide Description and Business Overview
6.11.3 Lunan Better Pharma Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lunan Better Pharma Injectable Suspension Budesonide Product Portfolio
6.11.5 Lunan Better Pharma Recent Developments/Updates
6.12 Shanghai Sine Promod
6.12.1 Shanghai Sine Promod Corporation Information
6.12.2 Shanghai Sine Promod Injectable Suspension Budesonide Description and Business Overview
6.12.3 Shanghai Sine Promod Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai Sine Promod Injectable Suspension Budesonide Product Portfolio
6.12.5 Shanghai Sine Promod Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Suspension Budesonide Industry Chain Analysis
7.2 Injectable Suspension Budesonide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Suspension Budesonide Production Mode & Process
7.4 Injectable Suspension Budesonide Sales and Marketing
7.4.1 Injectable Suspension Budesonide Sales Channels
7.4.2 Injectable Suspension Budesonide Distributors
7.5 Injectable Suspension Budesonide Customers
8 Injectable Suspension Budesonide Market Dynamics
8.1 Injectable Suspension Budesonide Industry Trends
8.2 Injectable Suspension Budesonide Market Drivers
8.3 Injectable Suspension Budesonide Market Challenges
8.4 Injectable Suspension Budesonide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Injectable Suspension Budesonide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Injectable Suspension Budesonide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Injectable Suspension Budesonide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Injectable Suspension Budesonide Sales (K L) of Key Manufacturers (2019-2024)
Table 5. Global Injectable Suspension Budesonide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Injectable Suspension Budesonide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Injectable Suspension Budesonide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Injectable Suspension Budesonide Average Price (US$/L) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Injectable Suspension Budesonide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Injectable Suspension Budesonide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Injectable Suspension Budesonide, Product Type & Application
Table 12. Global Key Manufacturers of Injectable Suspension Budesonide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable Suspension Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Suspension Budesonide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Suspension Budesonide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Injectable Suspension Budesonide Sales by Region (2019-2024) & (K L)
Table 18. Global Injectable Suspension Budesonide Sales Market Share by Region (2019-2024)
Table 19. Global Injectable Suspension Budesonide Sales by Region (2025-2030) & (K L)
Table 20. Global Injectable Suspension Budesonide Sales Market Share by Region (2025-2030)
Table 21. Global Injectable Suspension Budesonide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Injectable Suspension Budesonide Revenue Market Share by Region (2019-2024)
Table 23. Global Injectable Suspension Budesonide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Injectable Suspension Budesonide Revenue Market Share by Region (2025-2030)
Table 25. North America Injectable Suspension Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Injectable Suspension Budesonide Sales by Country (2019-2024) & (K L)
Table 27. North America Injectable Suspension Budesonide Sales by Country (2025-2030) & (K L)
Table 28. North America Injectable Suspension Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Injectable Suspension Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Injectable Suspension Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Injectable Suspension Budesonide Sales by Country (2019-2024) & (K L)
Table 32. Europe Injectable Suspension Budesonide Sales by Country (2025-2030) & (K L)
Table 33. Europe Injectable Suspension Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Injectable Suspension Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Injectable Suspension Budesonide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Injectable Suspension Budesonide Sales by Region (2019-2024) & (K L)
Table 37. Asia Pacific Injectable Suspension Budesonide Sales by Region (2025-2030) & (K L)
Table 38. Asia Pacific Injectable Suspension Budesonide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Injectable Suspension Budesonide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Injectable Suspension Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Injectable Suspension Budesonide Sales by Country (2019-2024) & (K L)
Table 42. Latin America Injectable Suspension Budesonide Sales by Country (2025-2030) & (K L)
Table 43. Latin America Injectable Suspension Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Injectable Suspension Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Injectable Suspension Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Injectable Suspension Budesonide Sales by Country (2019-2024) & (K L)
Table 47. Middle East & Africa Injectable Suspension Budesonide Sales by Country (2025-2030) & (K L)
Table 48. Middle East & Africa Injectable Suspension Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Injectable Suspension Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Injectable Suspension Budesonide Sales (K L) by Type (2019-2024)
Table 51. Global Injectable Suspension Budesonide Sales (K L) by Type (2025-2030)
Table 52. Global Injectable Suspension Budesonide Sales Market Share by Type (2019-2024)
Table 53. Global Injectable Suspension Budesonide Sales Market Share by Type (2025-2030)
Table 54. Global Injectable Suspension Budesonide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Injectable Suspension Budesonide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Injectable Suspension Budesonide Revenue Market Share by Type (2019-2024)
Table 57. Global Injectable Suspension Budesonide Revenue Market Share by Type (2025-2030)
Table 58. Global Injectable Suspension Budesonide Price (US$/L) by Type (2019-2024)
Table 59. Global Injectable Suspension Budesonide Price (US$/L) by Type (2025-2030)
Table 60. Global Injectable Suspension Budesonide Sales (K L) by Application (2019-2024)
Table 61. Global Injectable Suspension Budesonide Sales (K L) by Application (2025-2030)
Table 62. Global Injectable Suspension Budesonide Sales Market Share by Application (2019-2024)
Table 63. Global Injectable Suspension Budesonide Sales Market Share by Application (2025-2030)
Table 64. Global Injectable Suspension Budesonide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Injectable Suspension Budesonide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Injectable Suspension Budesonide Revenue Market Share by Application (2019-2024)
Table 67. Global Injectable Suspension Budesonide Revenue Market Share by Application (2025-2030)
Table 68. Global Injectable Suspension Budesonide Price (US$/L) by Application (2019-2024)
Table 69. Global Injectable Suspension Budesonide Price (US$/L) by Application (2025-2030)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 73. AstraZeneca Injectable Suspension Budesonide Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 78. Teva Injectable Suspension Budesonide Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 83. Mylan Injectable Suspension Budesonide Product
Table 84. Mylan Recent Developments/Updates
Table 85. Sandoz Corporation Information
Table 86. Sandoz Description and Business Overview
Table 87. Sandoz Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 88. Sandoz Injectable Suspension Budesonide Product
Table 89. Sandoz Recent Developments/Updates
Table 90. Cosmo Pharmaceuticals Corporation Information
Table 91. Cosmo Pharmaceuticals Description and Business Overview
Table 92. Cosmo Pharmaceuticals Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 93. Cosmo Pharmaceuticals Injectable Suspension Budesonide Product
Table 94. Cosmo Pharmaceuticals Recent Developments/Updates
Table 95. Salix Corporation Information
Table 96. Salix Description and Business Overview
Table 97. Salix Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 98. Salix Injectable Suspension Budesonide Product
Table 99. Salix Recent Developments/Updates
Table 100. Chiesi Farmaceutici Corporation Information
Table 101. Chiesi Farmaceutici Description and Business Overview
Table 102. Chiesi Farmaceutici Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 103. Chiesi Farmaceutici Injectable Suspension Budesonide Product
Table 104. Chiesi Farmaceutici Recent Developments/Updates
Table 105. Orion Corporation Corporation Information
Table 106. Orion Corporation Description and Business Overview
Table 107. Orion Corporation Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 108. Orion Corporation Injectable Suspension Budesonide Product
Table 109. Orion Corporation Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 113. Cipla Injectable Suspension Budesonide Product
Table 114. Cipla Recent Developments/Updates
Table 115. Synmosa Biopharma Corporation Information
Table 116. Synmosa Biopharma Description and Business Overview
Table 117. Synmosa Biopharma Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 118. Synmosa Biopharma Injectable Suspension Budesonide Product
Table 119. Synmosa Biopharma Recent Developments/Updates
Table 120. Lunan Better Pharma Corporation Information
Table 121. Lunan Better Pharma Description and Business Overview
Table 122. Lunan Better Pharma Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 123. Lunan Better Pharma Injectable Suspension Budesonide Product
Table 124. Lunan Better Pharma Recent Developments/Updates
Table 125. Shanghai Sine Promod Corporation Information
Table 126. Shanghai Sine Promod Description and Business Overview
Table 127. Shanghai Sine Promod Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 128. Shanghai Sine Promod Injectable Suspension Budesonide Product
Table 129. Shanghai Sine Promod Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Injectable Suspension Budesonide Distributors List
Table 133. Injectable Suspension Budesonide Customers List
Table 134. Injectable Suspension Budesonide Market Trends
Table 135. Injectable Suspension Budesonide Market Drivers
Table 136. Injectable Suspension Budesonide Market Challenges
Table 137. Injectable Suspension Budesonide Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injectable Suspension Budesonide
Figure 2. Global Injectable Suspension Budesonide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Injectable Suspension Budesonide Market Share by Type in 2023 & 2030
Figure 4. 0.5mg Product Picture
Figure 5. 1mg Product Picture
Figure 6. Global Injectable Suspension Budesonide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Injectable Suspension Budesonide Market Share by Application in 2023 & 2030
Figure 8. Respiratory Disease Treatment
Figure 9. Nose Disease Treatment
Figure 10. Inflammatory Bowel Disease Treatment
Figure 11. Other
Figure 12. Global Injectable Suspension Budesonide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Injectable Suspension Budesonide Market Size (2019-2030) & (US$ Million)
Figure 14. Global Injectable Suspension Budesonide Sales (2019-2030) & (K L)
Figure 15. Global Injectable Suspension Budesonide Average Price (US$/L) & (2019-2030)
Figure 16. Injectable Suspension Budesonide Report Years Considered
Figure 17. Injectable Suspension Budesonide Sales Share by Manufacturers in 2023
Figure 18. Global Injectable Suspension Budesonide Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Injectable Suspension Budesonide Players: Market Share by Revenue in 2023
Figure 20. Injectable Suspension Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Injectable Suspension Budesonide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Injectable Suspension Budesonide Sales Market Share by Country (2019-2030)
Figure 23. North America Injectable Suspension Budesonide Revenue Market Share by Country (2019-2030)
Figure 24. United States Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Injectable Suspension Budesonide Sales Market Share by Country (2019-2030)
Figure 27. Europe Injectable Suspension Budesonide Revenue Market Share by Country (2019-2030)
Figure 28. Germany Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Injectable Suspension Budesonide Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Injectable Suspension Budesonide Revenue Market Share by Region (2019-2030)
Figure 35. China Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Injectable Suspension Budesonide Sales Market Share by Country (2019-2030)
Figure 45. Latin America Injectable Suspension Budesonide Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Injectable Suspension Budesonide Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Injectable Suspension Budesonide Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Injectable Suspension Budesonide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Injectable Suspension Budesonide by Type (2019-2030)
Figure 55. Global Revenue Market Share of Injectable Suspension Budesonide by Type (2019-2030)
Figure 56. Global Injectable Suspension Budesonide Price (US$/L) by Type (2019-2030)
Figure 57. Global Sales Market Share of Injectable Suspension Budesonide by Application (2019-2030)
Figure 58. Global Revenue Market Share of Injectable Suspension Budesonide by Application (2019-2030)
Figure 59. Global Injectable Suspension Budesonide Price (US$/L) by Application (2019-2030)
Figure 60. Injectable Suspension Budesonide Value Chain
Figure 61. Injectable Suspension Budesonide Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
